GSK/Yamanouchi Vesicare Joint Venture Unaffected By Fujisawa Merger
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline does not expect its Vesicare joint venture with Yamanouchi to be affected by the merger between Yamanouchi and Fujisawa